D'amico AV - Search Results

1

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.

Carroll PR, Kantoff PW, Balk SP, Brown MA, D'amico AV, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, Mcleod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C; Second International Conference on Newer Approaches to Androgen Deprivation Therapy (ADT) in Prostate Cancer. Carroll PR, et al. Urology. 2002 Sep;60(3 Suppl 1):1-6. doi: 10.1016/s0090-4295(02)01559-5. Urology. 2002. PMID: 12231036 Review. No abstract available.

2

Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy.

D'Amico AV, Chang E, Garnick M, Kantoff P, Jiroutek M, Tempany CM. D'Amico AV, et al. Urology. 1998 Feb;51(2):287-92. doi: 10.1016/s0090-4295(97)00610-9. Urology. 1998. PMID: 9495713

3

Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors.

D'Amico AV, Schultz D, Schneider L, Hurwitz M, Kantoff PW, Richie JP. D'Amico AV, et al. J Urol. 2000 Jun;163(6):1797-801. J Urol. 2000. PMID: 10799185

4

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer.

D'Amico AV, Schultz D, Loffredo M, Dugal R, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA, Kantoff PW. D'Amico AV, et al. JAMA. 2000 Sep 13;284(10):1280-3. doi: 10.1001/jama.284.10.1280. JAMA. 2000. PMID: 10979115

5

Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials.

D'Amico AV, Whittington R, Malkowicz SB, Wu YH, Chen MH, Hurwitz M, Kantoff PW, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. D'Amico AV, et al. J Clin Oncol. 2000 Sep 15;18(18):3240-6. doi: 10.1200/JCO.2000.18.18.3240. J Clin Oncol. 2000. PMID: 10986056

6

Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.

D'Amico A. D'Amico A. Urology. 2001 Aug;58(2 Suppl 1):78-82. doi: 10.1016/s0090-4295(01)01246-8. Urology. 2001. PMID: 11502455

7

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer.

D'Amico AV, Saegaert T, Chen MH, Renshaw AA, George D, Oh W, Kantoff PW. D'Amico AV, et al. Cancer. 2002 Jul 15;95(2):275-80. doi: 10.1002/cncr.10673. Cancer. 2002. PMID: 12124826 Free article.

8

Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer.

D'Amico AV. D'Amico AV. Urology. 2002 Sep;60(3 Suppl 1):32-7; discussion 37-8. doi: 10.1016/s0090-4295(02)01566-2. Urology. 2002. PMID: 12231043 Review.

9

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era.

Ung JO, Richie JP, Chen MH, Renshaw AA, D'Amico AV. Ung JO, et al. Urology. 2002 Sep;60(3):458-63. doi: 10.1016/s0090-4295(02)01814-9. Urology. 2002. PMID: 12350484

10

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. D'Amico AV, et al. J Clin Oncol. 2003 Jun 1;21(11):2163-72. doi: 10.1200/JCO.2003.01.075. J Clin Oncol. 2003. PMID: 12775742

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters